S. Murray Sherman to Hypoglycemic Agents
This is a "connection" page, showing publications S. Murray Sherman has written about Hypoglycemic Agents.
Connection Strength
0.105
-
No Evidence of Increase in Calcitonin Concentrations or Development of C-Cell Malignancy in Response to Liraglutide for Up to 5 Years in the LEADER Trial. Diabetes Care. 2018 03; 41(3):620-622.
Score: 0.105